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Abstract
Urethral stricture disease affects many men worldwide. Traditionally, the
investigation of choice has been urethrography and the management of choice
has been urethrotomy/dilatation. In this review, we discuss the evidence behind
the use of ultrasonography in stricture assessment. We also discuss the factors
a surgeon should consider when deciding the management options with each
individual patient. Not all strictures are identical and surgeons should
appreciate the poor long-term results of urethrotomy/dilatation for strictures
longer than 2 cm, strictures in the penile urethra, recurrent strictures, and
strictures secondary to lichen sclerosus. These patients may benefit from
primary urethroplasty if they have many adverse features or secondary
urethroplasty after the first recurrence.
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Introduction
This update will concentrate on the advances in the investigation 
and management of urethral stricture disease in men. Traditionally, 
urologists have offered such men urethral dilatation/urethrotomy, 
which carries the risk of needing repeat interventions and a long-
term need to self-dilate the urethra on a regular basis. We aim to 
discuss the evidence relating to patient investigation and selection 
for more definitive surgery such as urethroplasty.
A urethral stricture is a narrowing of the urethra. A “true” stricture 
is the result of ischaemic spongiofibrosis manifesting as scar tissue 
in the corpus spongiosum1. Contraction of this scar tissue leads to a 
reduction in the urethral calibre, which leads to voiding difficulty. 
On the other hand, urethral distraction injuries occur as a result 
of blunt trauma distracting the two ends of the urethra apart and 
are not “true” strictures. Ischaemic spongiofibrosis may be due to 
infection such as gonococcal urethritis, inflammation such as lichen 
sclerosus, or instrumentation; however, the majority of strictures 
are idiopathic. It is reported that, in the US, on the basis of 10 public 
and private databases between 1992 and 2000, there were 5 million 
office visits per year and more than 5,000 inpatient admissions per 
year due to urethral strictures2.
There are many management options available for treating 
urethral stricture disease, commencing with less invasive urethral 
dilatation, urethral stenting and urethrotomy, and progressing to 
anastomotic and augmentation urethroplasty. The optimum man-
agement approach is often debated by urologists; some prefer a less 
invasive approach and perform urethrotomy/dilatation as first and 
even second line for all patients, whereas those who perform ure-
throplasty regularly recognise that urethroplasty may become more 
difficult after urethrotomy and advocate primary urethroplasty, as 
it is thought that a urethrotomy lengthens the stricture and leads to 
deepening of the spongiofibrosis, resulting in poorer blood supply 
to the urethra. Also, in a multivariate analysis of urethroplasty out-
comes, prior urethrotomy was found to be a risk factor for failure3. 
Others take a “middle of the road” approach and select patients in 
whom urethrotomy is likely to have a limited role and counsel them 
regarding primary urethroplasty. In this article, we aim to review 
the literature regarding the investigation and selection of patients 
for urethroplasty.
Discussion
Stricture evaluation
Much work has gone into providing a means of identifying the 
extent of a urethral stricture pre-operatively. Traditionally, a retro-
grade urethrogram is used to identify stricture density and length. 
Ideally, an antegrade and retrograde urethrogram could be per-
formed to fully characterise the stricture. A recent study has sug-
gested that the operating urologist may be better off performing and 
interpreting the urethrogram, as this led to the most accurate find-
ing of strictures and description of stricture length4. In this study, 
all urethrograms were performed by a urologist and therefore it is 
not known whether the radiologist would have obtained the same 
results had they performed and reported the studies. Certainly, in 
our practice, a sub-speciality uro-radiologist performs and reports 
the study and it is thereafter viewed by the operating surgeon.
Another method of stricture assessment involves the use of ultra-
sound. This can accurately assess the extent of ischaemic spong-
iofibrosis in the corpus spongiosum and this is often longer than the 
“white” stricture which is seen at endoscopy, which in turn is longer 
than the “narrowing” seen on the urethrogram5. A recent report from 
McAninch et al. has shown that this can pick up underlying spon-
giofibrosis, which changed the stricture length in 45% of patients 
over a urethrogram6. In this series of 232 men, the urethroplasty 
approach was changed in 19% of patients. Strictures which appear 
short on urethrography but have extensive underlying spongiofi-
brosis are important to identify as these are more likely to require 
substitution urethroplasty instead of anastomotic urethroplasty. 
In the series from McAninch et al., the mean stricture length was 
increased by the use of ultrasonography from 2 to 3.4 cm. Another 
study, of 40 patients, has suggested that ultrasound is accurate in 
assessing anterior urethral strictures and also provides more infor-
mation than the urethrogram alone7. Ultrasound has also been found 
to be equivalent to magnetic resonance urethrography and the latter 
is probably unnecessary for assessing the anterior urethra8.
Another important use for ultrasound, which has not been 
investigated, is in deciding which patients are likely to benefit from 
a urethral dilatation/urethrotomy or will likely require a urethro-
plasty. It is thought that by incising a stricture, the underlying fibro-
sis is lengthened and thus subsequent stricturing, if it recurs, is likely 
to lead to a longer stricture. In an interesting retrospective study, it 
was shown that bulbar strictures where urethrotomy/dilatation had 
been undertaken two or more times were longer and also recurred 
quicker than in those who underwent one or no transurethral 
surgery9. The difficulty here is that we have “the cause or effect 
scenario” as it cannot be proven, in this study, whether the strictures 
undergoing more transurethral surgery were longer and therefore 
more apparent symptomatically to begin with.
The capability of a urethra to heal without re-stricturing is reliant 
upon an adequate underlying blood supply and therefore knowl-
edge of underlying spongiofibrosis may well be beneficial in iden-
tifying those patients who may benefit from primary urethroplasty. 
A recent Société Internationale d’Urologie/International Consulta-
tion on Urological Diseases (SIU/ICUD) consultation for evalu-
ation and follow-up of urethral stricture disease concluded that 
urethrography and urethroscopy remain the investigations of choice 
for the anterior urethra10. The evidence for the use of ultrasound is 
currently limited but does show some promise in evaluating under-
lying spongiofibrosis and may help counsel patients better before 
undertaking surgery as to the type of surgery they may require.
Stricture management
Traditionally, the most commonly performed procedure for urethral 
stricture has been dilation/urethrotomy. A survey of 1,262 American 
urologists found that most urologists treat between 6 and 20 stric-
tures per year and over 90% performed dilatation/urethrotomy11. 
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It is noteworthy that 74% of urologists believed that urethroplasty 
should be performed only after repeated failure of endoscopic 
methods.
A randomised controlled trial reported by Steenkamp et al. 
reviewed 210 men, of whom 106 underwent dilatation and 104 
urethrotomy12. At 1 year, there was a success rate of 60% if the stric-
ture was less than 2 cm, 50% if it was between 2 and 4 cm, and 20% if 
it was more than 4 cm in length. In a subsequent publication, Heyns 
et al., working on the same dataset, looked at repeat dilatation/ 
urethrotomy and noted that after a single treatment 70% would be 
stricture-free at 3 months, 35–40% would remain stricture-free at 
48 months, and a secondary procedure was of limited benefit at 
24 months, but not at 48 months13. A third treatment was of no ben-
efit at all. Other authors have reported even worse success rates, 
with primary urethrotomy approaching even less than 40%14,15. 
However, these are retrospective case reports and caution should be 
applied when interpreting their findings.
Greenwell et al. concluded that, in terms of cost-effectiveness, the 
use of urethroplasty after failure of one urethrotomy/dilatation was 
likely to be the most cost-effective approach16. Contrastingly, Rourke 
and Jordan have suggested that treatment of short bulbar strictures 
by urethroplasty is more cost-effective than urethrotomy17. A calcu-
lated approach is that initial urethrotomy followed by urethroplasty 
is the most cost-effective approach if there is recurrence of the stric-
ture, unless the success rate of urethrotomy was likely to be inferior 
to 35%18. Certainly, experts who perform urethroplasty regularly 
do feel it is made more difficult by repeated interventions such as 
urethrotomy. A retrospective review by Roehrborn and McConnell 
reported doubling of the failure rate in patients with previous surgi-
cal manipulation19. Similarly, Breyer et al. reported a hazard ratio 
of 1.7 on multivariate analysis of 443 patients if they had previously 
undergone urethrotomy3.
The reasons some urologists offer repeat urethrotomy are manifold. 
A recent study of case logs from the US showed great disparity in 
the number of urethroplasties performed in different regions, and 
men were more likely to be referred for specialist intervention by 
newly certified urologists than established urologists20. All urolo-
gists are familiar with urethrotomy/dilatation and therefore are 
more likely to offer this than refer to another institute where ure-
throplasty is performed regularly. In addition, patient comorbidities 
may exclude a patient from having urethroplasty21. Similar findings 
were reported by a European study, in which 79% of Dutch urolo-
gists reported that they felt a urethroplasty should be offered only 
after failed urethrotomy15. The authors found that 20% of urologists 
would continue to perform urethrotomy for a 1 cm stricture even 
after two recurrences. Therefore, it transpires for some patients that 
urethroplasty is not considered at all or considered only when the 
stricture is lengthy and subsequent urethroplasty more difficult.
Table 1 lists the factors which should be considered as risk fac-
tors for recurrence of urethral strictures22. In our experience, bulbar 
strictures are likely to recur less often after urethrotomy than 
penile urethral strictures because of better blood supply in the 
bulbar urethra, although there are limited data on this in the lit-
erature. Strictures which recur after urethrotomy/dilatation are 
almost certainly likely to need further intervention after a repeat 
urethrotomy/dilatation. We feel that by assessing these in each 
individual patient, three categories of patients can be created. 
Those with multiple risk factors should proceed to urethroplasty 
if suitable, and those with two risk factors may undergo primary 
urethrotomy/dilatation but should be counselled regarding ure-
throplasty. Finally, those with only one risk factor could undergo 
urethrotomy/dilatation first. This approach, though useful in clini-
cal practice, does require some fine tuning, and only with emerging 
evidence will it be possible to give a weighting to each risk factor.
Follow-up
Many surgeons will rely upon the visual appearance of the urethra 
at cystourethroscopy; an ischaemic urethra looks white or grey, and 
healthy well-vascularised tissue appears pink. The narrowed por-
tion of the urethra may appear much shorter than the white area 
with underlying spongiofibrosis. Cystourethroscopy provides ear-
lier evidence of stricturing or recurrence usually prior to a reduction 
in flow rate23. The flow rate is not significantly affected until the 
urethral calibre is less than 11 Fr24. In our experience, we advocate 
symptom assessment and cystourethroscopy for follow-up. The 
frequency and length of follow-up should follow a risk-stratified 
approach as discussed above for patient assessment (Table 1). 
The evidence for this approach, however, is currently lacking in the 
literature.
Patients with strictures may also present with a multitude of symp-
toms which may or may not impact upon their quality of life25. In 
this regard, a Patient-Reported Outcome Measure (PROM) has 
been validated for this cohort26. This also takes account of sexual 
function and should be used in the assessment of patients pre- and 
post-operatively. A more recent report has shown this PROM to be 
able to detect post-operative changes after 2 years of follow-up27.
Future work
Questions remaining for the future include the use of ultrasound in 
deciding which options are beneficial for patients prior to the first 
urethrotomy or for urethroplasty. Further investigation is required 
into factors that lead to lower success with urethrotomy, which are 
also those leading to worse outcomes with urethroplasty. The results 
of the Open urethroplasty versus Endoscopic urethrotomy (OPEN) 
randomised controlled trial are eagerly awaited. This specifically 
looks at the use of urethroplasty or urethrotomy for recurrent stric-
tures. A Cochrane review has shown the dearth of randomised 
controlled data in this field and these are what we really require28. 
Table 1. Factors important for urethral stricture 
recurrence.
Factors Good prognosis Poor prognosis
Length <2cm >2cm
Location Bulbar urethra Penile urethra
Aetiology Idiopathic Inflammatory, Iatrogenic 
Lichen sclerosus
Recurrent No Yes
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Depending on the findings of the OPEN trial, the field should be 
able to progress in the correct direction and lead to better patient 
selection and, ultimately, improved patient outcomes.
Conclusions
From the discussion above, it is clear that proper assessment of ure-
thral strictures is required to dictate appropriate management. All 
too often, a stricture is seen via flexible cystoscopy and the patient 
placed on the waiting list for a urethrotomy which is left to a junior 
resident to “cut through”. Surgeons should appreciate that by cut-
ting through a stricture they may be lengthening the stricture as it 
relies on an adequate residual blood supply to heal without scar-
ring. It should be recognised that the success of their intervention 
is limited by certain stricture characteristics and not all strictures 
are the same. Variations in strictures should be noted and respected. 
Stricture length, location and aetiology have been shown to affect 
recurrence rate, and urologists should be able to classify strictures 
as high-, intermediate- and low-risk (Table 1). With these factors in 
mind, a urologist should be more equipped in counselling patients 
regarding their options for management and follow-up.
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